GDF15 inhibits early-stage adipocyte differentiation by enhancing HOP2 expression and suppressing C/EBPα expression
Molecular and Cellular Endocrinology · 2025
DOI: 10.1016/j.mce.2025.112461 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2025. Verfasst von Haeng Jun Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, School of Medicine, Ajou University, Suwon, Republic of Korea; Department of Molecular Science and Technology, Ajou Uni…. Hauptthemen laut MEDLINE: Growth Differentiation Factor 15, Adipocytes, Adipogenesis, CCAAT-Enhancer-Binding Protein-alpha. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Excessive adipocyte differentiation and accumulation contribute to the development of metabolic disorders. Growth differentiation factor 15 (GDF15) plays an essential role in energy homeostasis and is considered an anti-obesity factor; however, elevated serum levels of endogenous GDF15 have been reported in certain individuals with obesity. In this study, to gain a better understanding of this complex relationship between GDF15 levels and obesity, we investigated GDF15 expression and function during adipogenesis. Compared with mice fed a normal diet, those fed a short-term high-fat diet exhibited a reduction in epididymal white adipose tissue and serum GDF15 expression. These results were confirmed in human adipose-derived stem cells that showed reduced GDF15 expression during adipogenesis differentiation. During adipogenesis, GDF15 was primarily degraded via the autophagy lysosomal pathway, and GDF15 overexpression in pre-adipocytes inhibited adipogenesis by suppressing CCAAT enhancer binding protein alpha (C/EBPα). Furthermore, whereas we detected a reduction in homologous-pairing protein 2 (HOP2) expression during adipogenesis, expression increased in response to an overexpression of GDF15. Furthermore, following knockdown of HOP2 during GDF15 overexpression, there was no suppression of C/EBPα expression. These findings indicate that GDF15 undergoes lysosomal degradation via an autophagic pathway and suppresses adipocyte differentiation via the HOP2-mediated inhibition of C/EBPα expression. Collectively, our findings indicate that GDF15 could serve as a potential therapeutic target for the treatment of metabolic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, School of Medicine, Ajou University, Suwon, Republic of Korea; Department of Molecular Science and Technology, Ajou University, Suwon, Republic of Korea.
- Department of Otolaryngology, School of Medicine, Ajou University, Suwon, Republic of Korea.
- Department of Otolaryngology, School of Medicine, Ajou University, Suwon, Republic of Korea. Electronic address: ostium@ajou.ac.kr.
Zitieren
APA
Kim, H. J., Kang, S. U., Kim, H. J., Lee, Y. S., & Kim, C. H. (2025). GDF15 inhibits early-stage adipocyte differentiation by enhancing HOP2 expression and suppressing C/EBPα expression. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2025.112461
Vancouver
Kim HJ, Kang SU, Kim HJ, Lee YS, Kim CH. GDF15 inhibits early-stage adipocyte differentiation by enhancing HOP2 expression and suppressing C/EBPα expression. Molecular and Cellular Endocrinology. 2025. doi:10.1016/j.mce.2025.112461
BibTeX
@article{Kim2025,
author = {Kim, Haeng Jun and Kang, Sung-Un and Kim, Hyo Jeong and Lee, Yun Sang and Kim, Chul-Ho},
title = {GDF15 inhibits early-stage adipocyte differentiation by enhancing HOP2 expression and suppressing C/EBPα expression},
journal = {Molecular and Cellular Endocrinology},
year = {2025},
doi = {10.1016/j.mce.2025.112461}
}
EUVIMED